# Nuclide record cellectar (company). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/companies/cellectar/>
  a schema:Organization ;
  nuclide:kind "company" ;
  schema:identifier "cellectar" ;
  schema:name "Cellectar Biosciences"@en ;
  schema:alternateName "Cellectar Biosciences, Inc."@en, "Cellectar"@en ;
  schema:description "Cellectar is a New Jersey radiopharmaceutical company whose iodine-131 phospholipid drug conjugate iopofosine targets the lipid rafts of cancer cells, with a pivotal trial (CLOVER-WaM) in relapsed Waldenström macroglobulinaemia."@en ;
  schema:url <https://nuclide.cc/companies/cellectar/>, <https://www.cellectar.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.cellectar.com>, <https://clinicaltrials.gov/search?lead=Cellectar%20Biosciences> ;
  nuclide:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  nuclide:related <https://nuclide.cc/isotopes/i-131/> ;
  nuclide:trials <https://nuclide.cc/trials/nct02952508/> .